These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 27271452)

  • 1. Markers of calcium and phosphate metabolism and osteopenic syndrome in patients with coronary artery disease.
    Golovkin AS; Kokov AN; Masenko V; Khryachkova ON; Malyuta Е; Barbarash OL
    Panminerva Med; 2016 Dec; 58(4):253-262. PubMed ID: 27271452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Biomarkers of Mineral and Bone Metabolism and Removal of Calcium and Phosphate in Hemodialysis.
    Debowska M; Dai L; Wojcik-Zaluska A; Poleszczuk J; Zaluska W; Lindholm B; Waniewski J
    Blood Purif; 2020; 49(1-2):71-78. PubMed ID: 31726453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vascular calcification and serum markers].
    Yoshida M; Tomiyama H; Yamashina A
    Clin Calcium; 2010 Nov; 20(11):1694-9. PubMed ID: 21037390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Cathepsin K Plasma Level may Reflect an Association of Osteopoenia/Osteoporosis with Coronary Atherosclerosis and Coronary Artery Calcification in Male Patients with Stable Angina.
    Barbarash OL; Lebedeva NB; Kokov AN; Novitskaya AA; Hryachkova ON; Voronkina AV; Raskina TA; Kashtalap VV; Kutikhin AG; Shibanova IA
    Heart Lung Circ; 2016 Jul; 25(7):691-7. PubMed ID: 26988144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Markers of calcium--phosphate metabolism and bones alterations in long term kidney transplant patients].
    Spiechowicz U; Kokot F; Wiecek A
    Przegl Lek; 2003; 60(11):690-4. PubMed ID: 15058034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Serum Parathyroid Hormone, Osteocalcin and Alkaline Phosphatase Are Associated with a Long-Term Adverse Cardiovascular Outcome after Coronary Artery Bypass Graft Surgery.
    Barbarash O; Zykov M; Kashtalap V; Hryachkova O; Kokov A; Gruzdeva O; Shibanova I; Kutikhin A
    Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31597282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of coronary artery lesion in men with osteopenic syndrome and coronary artery disease].
    Kokov AN; Maliuta EB; Masenko VL; Sigareva AA; Fanaskov VB; Tarasov RS; Raskina TA; Shibanova IA; Barbarash OL
    Ter Arkh; 2014; 86(3):65-70. PubMed ID: 24779073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
    Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
    Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CIP and CAP fragments of parathormone and selected parameters of calcium-phosphate balance in patients with chronic kidney disease treated with repeated haemodialysis].
    Polak-Jonkisz D; Zwolińska D; Nahaczewska W
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):25-8. PubMed ID: 20529602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of plaque calcification regulators osteoprotegerin and matrix Gla-proteins in stable angina and acute myocardial infarction.
    Margonato A; Gorla R; Macchi A; Buzzetti F; Franzoni I; Pedrigi MC; Rosa I; Sirtori M; Villa I; Rubinacci A
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):156-62. PubMed ID: 24566391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular calcification in end-stage renal disease patients.
    Nitta K; Ogawa T
    Contrib Nephrol; 2015; 185():156-67. PubMed ID: 26023025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineral-bone metabolism markers in young hemodialysis patients.
    Osorio A; Ortega E; Torres JM; Sanchez P; Ruiz-Requena E
    Clin Biochem; 2011 Dec; 44(17-18):1425-8. PubMed ID: 21933667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone density and mineral metabolism in calcitonin-deficiency patients].
    Cappelli C; Cottarelli C; Cumetti D; Agosti B; Gandossi E; Rizzoni D; Agabiti Rosei E
    Minerva Endocrinol; 2004 Mar; 29(1):1-10. PubMed ID: 15258552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder.
    Jiang JQ; Lin S; Xu PC; Zheng ZF; Jia JY
    Nephrology (Carlton); 2011 Aug; 16(6):588-94. PubMed ID: 21649792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis and treatment of vascular calcification in CKD].
    Brancaccio D; Gallieni M; Pasho S; Fallabrino G; Olivi L; Volpi E; Ciceri P; Missaglia E; Ronga C; Brambilla C; Butti A; Rocca-Rey L; Chiarelli G; Cozzolino M
    G Ital Nefrol; 2009; 26 Suppl 45():S20-7. PubMed ID: 19382090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.